Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Dissociative Identity Disorder

3,4-methylenedioxyamphetamine has been researched along with Dissociative Identity Disorder in 2 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Dissociative Identity Disorder: A dissociative disorder in which the individual adopts two or more distinct personalities. Each personality is a fully integrated and complex unit with memories, behavior patterns and social friendships. Transition from one personality to another is sudden.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buttsworth, J1
Abse, DW1

Other Studies

2 other studies available for 3,4-methylenedioxyamphetamine and Dissociative Identity Disorder

ArticleYear
"Sybil"--a psychotherapist's view.
    The Medical journal of Australia, 1978, Mar-11, Volume: 1, Issue:5

    Topics: Dissociative Identity Disorder; Female; Humans; Love; Psychotherapy; Transference, Psychology

1978
Delusional identity and the double.
    Psychiatry, 1976, Volume: 39, Issue:2

    Topics: Delusions; Dissociative Identity Disorder; Female; Humans; Identification, Psychological; Literature

1976